Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.
- 28 Downloads
To the Editor,
We read with great interest the recent paper by Wojszel et al. published recently in Journal of Thrombosis and Thrombolysis . In the article, the authors suggested that Oral anticoagulant (OACs) are often underused in elderly patients with atrial fibrillation (AF) because frailty status and anemia diagnosis. We have showed similar results in our patients and we would like to make some comments. We performed an analysis in 250 consecutive geriatric patients (123 males and 127 females; median age 78.9 years) with AF admitted to an acute internal Unit of an hospital in Cagliari, coming from the Emergency Department to evaluate trends in OACs use in real world. We examine the possibility of prescribing the direct oral anticoagulants (DOACs) and their actual prescription at discharge. Our data showed that at admission the patients with anticoagulant therapy (ACs) were 158 (9 with Heparin, 44 with DOACs, 105 with Vitamin K antagonist (AVK)). At discharge the number of...
Compliance with ethical standards
Conflict of interest
The authors have no financial or other conflicts of interest
- 2.Marzec LN, Goscch KL, Chan PS et al (2015) Abstract 14902: the introduction of novel oral anticoagulants has improved overall oral anticoagulants rates in atrial fibrillation: insights from the NCDR PINNACLE Registry. CirculationGoogle Scholar
- 4.Brais C, Larochelle J, Turgeon MH, Blais L, Farand P (2017) Predictors of direct oral anticoagulants utilization for thromboembolism prevention in atrial fibrillation. J Pharm Sci 20:8–14Google Scholar